Ad
ACIU Short Information AC Immune SA
home / stock / aciu / aciu short
Short Information | AC Immune SA (NASDAQ:ACIU)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 406,446 |
| Total Actual Volume | 2,840,781 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 20,322 |
| Average Short Percentage | 16.79% |
Is there a ACIU Short Squeeze or Breakout about to happen?
See the ACIU Short Analysis for free Sign up or Login
Powered by Squeeze Report
ACIU Twenty Trading Day's Volume to Short Volume Chart
ACIU Twenty Trading Day Price Chart
ACIU Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 01-22-2025 | $2.7 | $2.71 | $2.74 | $2.64 | 112,829 | 9,380 | 8.31% |
| 01-21-2025 | $2.72 | $2.65 | $2.73 | $2.62 | 134,951 | 22,201 | 16.45% |
| 01-17-2025 | $2.65 | $2.68 | $2.7147 | $2.65 | 74,509 | 14,746 | 19.79% |
| 01-16-2025 | $2.68 | $2.64 | $2.74 | $2.56 | 224,004 | 35,693 | 15.93% |
| 01-15-2025 | $2.69 | $2.68 | $2.7904 | $2.62 | 114,796 | 13,022 | 11.34% |
| 01-14-2025 | $2.64 | $2.61 | $2.83 | $2.6 | 174,542 | 16,661 | 9.55% |
| 01-13-2025 | $2.67 | $2.61 | $2.72 | $2.6 | 178,634 | 19,626 | 10.99% |
| 01-10-2025 | $2.82 | $2.72 | $2.85 | $2.66 | 73,277 | 12,127 | 16.55% |
| 01-08-2025 | $2.92 | $2.8 | $2.92 | $2.75 | 71,141 | 13,155 | 18.49% |
| 01-07-2025 | $3 | $2.93 | $3.0626 | $2.91 | 119,032 | 22,526 | 18.92% |
| 01-06-2025 | $3 | $2.98 | $3.094 | $2.9599 | 124,960 | 29,101 | 23.29% |
| 01-03-2025 | $2.89 | $2.98 | $2.99 | $2.87 | 187,917 | 63,121 | 33.59% |
| 01-02-2025 | $2.7 | $2.85 | $2.94 | $2.7 | 139,924 | 22,332 | 15.96% |
| 12-31-2024 | $2.71 | $2.7 | $2.9118 | $2.64 | 96,921 | 24,545 | 25.32% |
| 12-30-2024 | $2.71 | $2.67 | $2.73 | $2.63 | 86,063 | 12,086 | 14.04% |
| 12-27-2024 | $2.8 | $2.73 | $2.9 | $2.73 | 511,073 | 26,573 | 5.2% |
| 12-26-2024 | $2.67 | $2.705 | $2.76 | $2.6 | 36,550 | 7,464 | 20.42% |
| 12-24-2024 | $2.68 | $2.68 | $3.0699 | $2.6259 | 37,842 | 9,181 | 24.26% |
| 12-23-2024 | $2.66 | $2.68 | $2.75 | $2.65 | 105,835 | 25,868 | 24.44% |
| 12-20-2024 | $2.71 | $2.68 | $2.7718 | $2.63 | 235,981 | 7,038 | 2.98% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome ACI-24.060 was generally safe and well tolerated in individuals with Down syndrome with no serious adverse events related to the study drug No cases of amyloid-related imaging abnormalitie...
-
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein antibody levels on average 16-fold higher than placebo after 3 immunizations 100%...
-
AC Immune to Present at the Jefferies 2024 London Healthcare Conference Lausanne, Switzerland, November 13, 2024 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Ma...